Stevioside inhibits experimental fibrosis by down‐regulating profibrotic Smad pathways and blocking hepatic stellate cell activation-Reference-Cited by-同舟云学术

Stevioside inhibits experimental fibrosis by down‐regulating profibrotic Smad pathways and blocking hepatic stellate cell activation

Published:2019-01-10 Issue:6 Volume:124 Page:670-680
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Casas‐Grajales Sael¹,Alvarez‐Suarez Diana¹,Ramos‐Tovar Erika¹,Dayana Buendía‐Montaño Laura¹,Reyes‐Gordillo Karina²³,Camacho Javier¹,Tsutsumi Víctor⁴,Lakshman M. Raj²³,Muriel Pablo¹

Affiliation:

1. Department of Pharmacology Cinvestav‐IPN Mexico City Mexico

2. Department of Biochemistry and Molecular Biology, School of Medicine and Health Science The George Washington University Medical Center Washington District of Columbia

3. Lipid Research Laboratory VA Medical Center Washington District of Columbia

4. Department of Infectomics and Molecular Pathogenesis Cinvestav‐IPN Mexico City Mexico

Funder

Consejo Nacional de Ciencia y Tecnología

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13194

Reference39 articles.